CN1564690A - 四环素衍生物及其使用方法 - Google Patents

四环素衍生物及其使用方法 Download PDF

Info

Publication number
CN1564690A
CN1564690A CNA028197224A CN02819722A CN1564690A CN 1564690 A CN1564690 A CN 1564690A CN A028197224 A CNA028197224 A CN A028197224A CN 02819722 A CN02819722 A CN 02819722A CN 1564690 A CN1564690 A CN 1564690A
Authority
CN
China
Prior art keywords
alkyl
product
tetracycline
doxycycline
filtered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA028197224A
Other languages
English (en)
Chinese (zh)
Inventor
约瑟夫·拉弗卡
理查德·J·阿布林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tetragenex Pharmaceuticals Inc
Original Assignee
Tetragenex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tetragenex Pharmaceuticals Inc filed Critical Tetragenex Pharmaceuticals Inc
Publication of CN1564690A publication Critical patent/CN1564690A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C07C237/26—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton of a ring being part of a condensed ring system formed by at least four rings, e.g. tetracycline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
    • C07C2603/42—Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
    • C07C2603/44—Naphthacenes; Hydrogenated naphthacenes
    • C07C2603/46—1,4,4a,5,5a,6,11,12a- Octahydronaphthacenes, e.g. tetracyclines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CNA028197224A 2001-10-05 2002-10-04 四环素衍生物及其使用方法 Pending CN1564690A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32750201P 2001-10-05 2001-10-05
US60/327,502 2001-10-05

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CNA2006100992267A Division CN1961885A (zh) 2001-10-05 2002-10-04 四环素衍生物在制药中的应用

Publications (1)

Publication Number Publication Date
CN1564690A true CN1564690A (zh) 2005-01-12

Family

ID=23276795

Family Applications (2)

Application Number Title Priority Date Filing Date
CNA028197224A Pending CN1564690A (zh) 2001-10-05 2002-10-04 四环素衍生物及其使用方法
CNA2006100992267A Pending CN1961885A (zh) 2001-10-05 2002-10-04 四环素衍生物在制药中的应用

Family Applications After (1)

Application Number Title Priority Date Filing Date
CNA2006100992267A Pending CN1961885A (zh) 2001-10-05 2002-10-04 四环素衍生物在制药中的应用

Country Status (10)

Country Link
US (4) US7214669B2 (https=)
EP (1) EP1439843A4 (https=)
JP (1) JP2005505588A (https=)
CN (2) CN1564690A (https=)
AU (1) AU2002341970B2 (https=)
CA (1) CA2462572C (https=)
MY (1) MY133403A (https=)
NO (1) NO20041272L (https=)
RU (1) RU2300380C2 (https=)
WO (1) WO2003030819A2 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102631356A (zh) * 2012-04-11 2012-08-15 刘誉 4-去二甲氨基四环素衍生物在抗幽门螺旋杆菌方面的用途
CN107108472A (zh) * 2014-10-23 2017-08-29 四相制药公司 半合成方法
CN110156624A (zh) * 2019-05-29 2019-08-23 李玮 一种米诺环素及其衍生物的合成方法

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020132798A1 (en) * 2000-06-16 2002-09-19 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
US7094806B2 (en) * 2000-07-07 2006-08-22 Trustees Of Tufts College 7, 8 and 9-substituted tetracycline compounds
WO2002072506A2 (en) * 2001-03-13 2002-09-19 Paratek Pharmaceuticals, Inc. 7-pyrollyl tetracycline compounds and methods of use thereof
EA013835B1 (ru) * 2001-03-13 2010-08-30 Пэрэтек Фамэсьютикэлс, Инк. Замещенные соединения тетрациклина (варианты), фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния субъекта
RU2300380C2 (ru) * 2001-10-05 2007-06-10 Тетрадженекс Фармасьютикалс, Инк. Производные тетрациклина и способы их применения
US20050026833A1 (en) * 2001-11-08 2005-02-03 Rabbani Shafaat Ahmed PSP-94: use for treatment of hypercalcemia and bone metastasis
ES2551708T3 (es) * 2002-01-08 2015-11-23 Paratek Pharmaceuticals, Inc. Compuestos de 4-desdimetilamino tetraciclina
CA2503446C (en) 2002-10-24 2012-12-18 Paratek Pharmaceuticals, Inc. Methods of using substituted tetracycline compounds to modulate rna
US20060287283A1 (en) * 2003-07-09 2006-12-21 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
US20050143352A1 (en) 2003-07-09 2005-06-30 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
US8012950B2 (en) * 2003-08-29 2011-09-06 Wisconsin Alumni Research Foundation Method to diagnose and treat degenerative joint disease
JP5010284B2 (ja) * 2004-01-15 2012-08-29 パラテック ファーマシューティカルズ インコーポレイテッド テトラサイクリン化合物の芳香族ａ環誘導体
SI1753713T1 (sl) 2004-05-21 2017-01-31 President And Fellows Of Harvard College Sinteza tetraciklinov in njihovih analogov
EP1805134B1 (en) 2004-10-25 2012-06-20 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines and methods of use thereof
CA2597212A1 (en) 2005-02-04 2006-08-10 Paratek Pharmaceuticals, Inc. 11a, 12-derivatives of tetracycline compounds
AR057033A1 (es) * 2005-05-27 2007-11-14 Wyeth Corp Tigeciclina y metodos para preparar 9-nitrominociclina
AR057032A1 (es) * 2005-05-27 2007-11-14 Wyeth Corp Tigeciclina y metodos de preparacion
AR057324A1 (es) * 2005-05-27 2007-11-28 Wyeth Corp Tigeciclina y metodos para preparar 9-aminominociclina
WO2007117639A2 (en) * 2006-04-07 2007-10-18 The President And Fellows Of Harvard College Synthesis of tetracyclines and analogues thereof
EP2431469A3 (en) * 2006-05-15 2012-05-30 Paratek Pharmaceuticals, Inc. Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
EP2487160B1 (en) * 2006-10-11 2016-02-03 President and Fellows of Harvard College Synthesis of Enone Intermediate
US8440646B1 (en) 2006-10-11 2013-05-14 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of Bacillus anthracis infections
WO2010126607A2 (en) 2009-04-30 2010-11-04 President And Fellows Of Harvard College Synthesis of tetracyclines and intermediates thereto
ES2469829T3 (es) * 2009-11-26 2014-06-20 Sandoz Ag Reacción de compuestos orgánicos con bajas cantidades de hidrógeno
WO2011109899A1 (en) * 2010-03-10 2011-09-15 University Health Network Use of tigecycline for treatment of cancer
EP2852383A4 (en) * 2012-05-21 2016-03-16 Dcb Usa Llc METHODS OF DRUG TEST USING THE ZEBRAFIC MODEL AND COMPOUNDS TESTED THEREIN
EP3612540A1 (en) 2017-04-20 2020-02-26 Rising Tide Foundation Triphenylphosphonium-tethered tetracycyclines for use in treating cancer
AU2022215936A1 (en) * 2021-02-03 2023-08-24 Consejo Nacional De Investigaciones Científicas Y Técnicas (Conicet) Chemically coupled transporter for low-hydrophobicity bioactive drugs into the central nervous system

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1063598B (de) * 1957-02-14 1959-08-20 Hoechst Ag Verfahren zur Herstellung von wasserloeslichen Derivaten der Tetracycline
DE1088481B (de) * 1958-01-29 1960-09-08 American Cyanamid Co Verfahren zur Herstellung neuer Verbindungen der Tetracyclinreihe
US2997471A (en) * 1958-08-18 1961-08-22 Bristol Myers Co Tetracycline derivatives
US3104240A (en) * 1958-08-18 1963-09-17 Bristol Myers Co Mannich bases of tetracycline antibiotics
US3026284A (en) * 1959-05-13 1962-03-20 Westinghouse Electric Corp Process of treating a thermoplastic amine-aldehyde resin with a thermosetting additive and product obtained therefrom
US3029284A (en) * 1960-09-14 1962-04-10 Pfizer & Co C Nu-dealkylation of carboxamido-nu-alkyltetracycline and its analogs
US3338963A (en) * 1960-10-28 1967-08-29 American Cyanamid Co Tetracycline compounds
US3509184A (en) * 1961-08-18 1970-04-28 Pfizer & Co C Anthracyclidine-acetic acid derivatives
US3502696A (en) * 1961-08-18 1970-03-24 Pfizer & Co C Antibacterial agents
US3829453A (en) * 1961-08-18 1974-08-13 Pfizer Octahydroanthracene-2-aminoacetic acids and esters and mixed anhydrides thereof
US3772363A (en) * 1961-08-18 1973-11-13 Pfizer 3,4,10-trioxo octahydroanthracene-2-aminoacetic acids and derivatives thereof
US3145228A (en) * 1962-09-06 1964-08-18 Pfizer & Co C 5-alkoxy-and 5-benzyloxy-tetracycline, derivatives and analogues thereof
US3265732A (en) * 1964-02-28 1966-08-09 American Cyanamid Co Novel 5alpha, 6-anhydrotetracyclines
US3609188A (en) * 1964-10-29 1971-09-28 American Cyanamid Co 4-dedimethylamino-4-substituted-amino-6-demethyltetracyclines
US3326761A (en) * 1964-11-16 1967-06-20 Pfizer & Co C 6-demethyl-6-deoxytetracycline, anti-tumor antibiotic
US3345370A (en) * 1965-03-16 1967-10-03 American Cyanamid Co 4-(n-mono-substituted) hydrazones of 4-dedimethylamino-4-oxo-tetracycline
US3388162A (en) * 1966-03-14 1968-06-11 American Cyanamid Co 7-and/or 9-nitro or amino tetracyclines
US3515731A (en) * 1966-06-17 1970-06-02 Pfizer & Co C Antibacterial agents
US3849493A (en) * 1966-08-01 1974-11-19 Pfizer D-ring substituted 6-deoxytetracyclines
US3345410A (en) * 1966-12-01 1967-10-03 American Cyanamid Co Substituted 7- and/or 9-amino tetracyclines
US3502660A (en) * 1967-01-12 1970-03-24 Pfizer & Co C 2-((5'-(3' and/or 4'-substituted)isoxazoyl) methylidene)-3,4,10-trioxo-1,2,3,4,4a,9,9a,10-octahydroanthracenes
FR1520600A (fr) * 1967-02-27 1968-04-12 Snecma Perfectionnements aux turbo-machines à flux axial, et en particulier aux compresseurs axiaux à deux rotors imbriqués contrarotatifs
US3824285A (en) * 1967-09-13 1974-07-16 Pfizer 4-oxo-4-dedimethylaminotetracycline-4,6-hemiketals
US3622627A (en) * 1967-09-13 1971-11-23 Pfizer 4-dedimethylaminatetracycline and 5a, 6-anhydro derivatives thereof
US4704383A (en) * 1983-12-29 1987-11-03 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
USRE34656E (en) 1983-12-29 1994-07-05 The Research Foundation Of State University Of New York Use of tetracycline to enhance bone protein synthesis and/or treatment of bone deficiency
US4925833A (en) * 1983-12-29 1990-05-15 The Research Foundation Of State University Of New York Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis
US4666897A (en) * 1983-12-29 1987-05-19 Research Foundation Of State University Inhibition of mammalian collagenolytic enzymes by tetracyclines
US4935412A (en) * 1983-12-29 1990-06-19 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
US5122519A (en) * 1989-06-27 1992-06-16 American Cyanamid Company Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
US5045538A (en) * 1990-06-28 1991-09-03 The Research Foundation Of State University Of New York Inhibition of wasting and protein degradation of mammalian muscle by tetracyclines
US5776898A (en) * 1991-05-14 1998-07-07 Dana-Farber Cancer Institute Method for treating a tumor with a chemotherapeutic agent
US5494903A (en) * 1991-10-04 1996-02-27 American Cyanamid Company 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
US5442059A (en) * 1992-08-13 1995-08-15 American Cyanamid Company 9-[(substituted glycyl)amido)]-6-demethyl-6-deoxytetracyclines
US5420272A (en) * 1992-08-13 1995-05-30 American Cyanamid Company 7-(substituted)-8-(substituted)-9-](substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
DK0599397T3 (da) * 1992-11-17 1996-09-16 Univ New York State Res Found Tetracycliner, herunder non-mikrobielle, kemisk-modificerede tetracycliner, inhiberer overdreven collagentværbinding ved diabetes
WO1995022529A1 (en) * 1994-02-17 1995-08-24 Pfizer Inc. 9-(substituted amino)-alpha-6-deoxy-5-oxy tetracycline derivatives, their preparation and their use as antibiotics
EP0733369A1 (en) * 1995-03-23 1996-09-25 Stichting REGA V.Z.W. Protease inhibitors, a DNA construct for the expression of a protease and a process for measuring proteases and/or protease inhibitors
US5837696A (en) * 1997-01-15 1998-11-17 The Research Foundation Of State University Of New York Method of inhibiting cancer growth
US6277061B1 (en) * 1998-03-31 2001-08-21 The Research Foundation Of State University Of New York Method of inhibiting membrane-type matrix metalloproteinase
US6506740B1 (en) * 1998-11-18 2003-01-14 Robert A. Ashley 4-dedimethylaminotetracycline derivatives
DE69932846T2 (de) * 1998-11-18 2007-03-15 Collagenex Pharmaceuticals, Inc. Neue 4-dedimethylaminotetracyclinderivate
EA200201046A1 (ru) * 2000-03-31 2003-04-24 Трастис Оф Тафтс Коллидж 7- или 9-замещенные соединения тетрациклина, способ их получения (варианты), фармацевтическая композиция, способ лечения состояния, чувствительного к действию тетрациклина, у млекопитающего и реакционноспособное промежуточное производное
RU2300380C2 (ru) * 2001-10-05 2007-06-10 Тетрадженекс Фармасьютикалс, Инк. Производные тетрациклина и способы их применения

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102631356A (zh) * 2012-04-11 2012-08-15 刘誉 4-去二甲氨基四环素衍生物在抗幽门螺旋杆菌方面的用途
CN107108472A (zh) * 2014-10-23 2017-08-29 四相制药公司 半合成方法
CN110156624A (zh) * 2019-05-29 2019-08-23 李玮 一种米诺环素及其衍生物的合成方法

Also Published As

Publication number Publication date
US20040067912A1 (en) 2004-04-08
AU2002341970B2 (en) 2008-02-14
CN1961885A (zh) 2007-05-16
JP2005505588A (ja) 2005-02-24
US20050267079A1 (en) 2005-12-01
RU2300380C2 (ru) 2007-06-10
WO2003030819A3 (en) 2004-01-08
RU2004109986A (ru) 2005-02-20
CA2462572A1 (en) 2003-04-17
CA2462572C (en) 2008-11-18
US20070142338A1 (en) 2007-06-21
EP1439843A4 (en) 2007-01-03
WO2003030819A2 (en) 2003-04-17
US20070149488A1 (en) 2007-06-28
EP1439843A2 (en) 2004-07-28
US7214669B2 (en) 2007-05-08
NO20041272L (no) 2004-07-02
MY133403A (en) 2007-11-30
US20050245491A9 (en) 2005-11-03

Similar Documents

Publication Publication Date Title
CN1564690A (zh) 四环素衍生物及其使用方法
CN1252040C (zh) 新颖的芳基、链烯基、和炔基4－脱二甲氨基四环素衍生物
CN1071415A (zh) 新颖的9-氨基-7-(取代)-6-脱甲基-6-脱氧四环素
CN1033971C (zh) 9-[(取代甘氨酰)酰氨基)]-6-去甲基-6-去氧四环素
CN1135982C (zh) 含n-酰基-2,3-苯并二氮杂�衍生物的药物组合物的制备方法
CN1048719C (zh) 7－(取代－)－8－(取代)－9－(取代的氨基)－6－去甲基－6－去氧四环素及其制备方法、组合物和用途
CN1071334C (zh) 糖肽抗生素衍生物
CN1172919C (zh) 芳烷醇哌嗪衍生物及其在制备抗抑郁症药物中的应用
CN100335491C (zh) 具有抗炎活性的大环内酯化合物
CN1087626A (zh) 新颖的7-(取代)-8-(取代)-9-[(取代的甘氨酰)酰氨基]-6-去甲基-6-去氧四环素
CN1430600A (zh) 7－和9－氨基甲酸酯、脲、硫脲、硫代氨基甲酸酯,和杂芳基－氨基取代的四环素化合物
CN1538967A (zh) 杂环化合物和以其为有效成分的抗肿瘤药
CN1195519C (zh) 5－HT再摄取抑制剂与h5－HT1B拮抗剂或部分激动剂的组合物
CN1209119A (zh) 新的三环化合物及含有它们的药物组合物
CN1052483A (zh) 糖肽衍生物的改进及有关的糖肽衍生物
CN1538951A (zh) 用作多形核和单核细胞趋化性抑制剂的R-2-芳基-丙酸的ω-氨烷基酰胺
CN1200699C (zh) 蒽酮衍生物及其在淀粉样变性中的用途
CN1547472A (zh) 作为d-丙氨酰-d-丙氨酸连接酶抑制剂的稠合嘧啶
CN1280276C (zh) 9－氨基吖啶衍生物及其制备方法
CN1890226A (zh) 四环素类的恶唑衍生物
CN86104787A (zh) 制备聚-4-氨基吡咯-2-甲酰胺基衍生物的方法
CN85101425A (zh) 带有次苯基的斯伯格埃林有关化合物及其制备方法
CN1922190A (zh) 3－吡啶甲基头胞化合物
CN1104411A (zh) 抑制鸟氨酸脱羧酶的环状氨基氧基化合物
CN1148378C (zh) 15-脱氧精胍林类似物、其制备方法及其治疗应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication